Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 12.1 Chief Executive Officer Certification Pursuant to Section 302
- 12.2 Chief Financial Officer Certification Pursuant to Section 302
- 13.1 Chief Executive Officer Certification Pursuant to Section 906
- 13.2 Chief Financial Officer Certification Pursuant to Section 906
- 15.1 Consent of Pricewaterhousecoopers Zhong Tian Cpas Limited Company
- 15.2 Consent of Fangda Partners
SHP similar filings
Filing view
External links
[Letterhead of Fangda Partners]
April 29, 2011
ShangPharma Corporation
No. 5 Building, 998 Halei Road
Zhangjiang Hi-Tech Park, Pudong New Area
Shanghai, 201203
People’s Republic of China
Dear Sirs,
We consent to the reference to our firm under the headings “Risk Factors” and “Regulation” in ShangPharma Corporation’s Annual Report on Form 20-F for the year ended December 31, 2010, which will be filed with the Securities and Exchange Commission (the “SEC”). We also consent to the filing with the SEC of this consent letter as an exhibit to the Annual Report on Form 20-F for the year ended December 31, 2010.
Yours faithfully,
/s/ Fangda Partners |
| Fangda Partners |